ACORDA THERAPEUTICS INC (ACOR) Stock Earnings & Estimates
USA - NASDAQ:ACOR - US00484M7002 - Common Stock
0.661 USD
-0.22 (-24.86%)
0.5656 USD
-0.1 (-14.43%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 129.1M -15.62% | 118.6M -8.13% | 117.633M -0.82% | |
| EBITDA YoY % growth | -39M -254.76% | -2.2M 94.36% | 18.036M 919.82% | |
| EBIT YoY % growth | -73M -353.42% | -35M 52.05% | -13.63M 61.06% | |
| Operating Margin | -56.55% | -29.51% | -11.59% | |
| EPS YoY % growth | -6.43 28.87% | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -7.16 -1,201.82% | % | ||
| Q4 2022 Q2Q % growth | 0.57 185.07% | % | ||
| Q3 2022 Q2Q % growth | -0.55 61.54% | % | ||
| Q2 2022 Q2Q % growth | -3.15 -68.45% | % | ||
| Q1 2022 Q2Q % growth | -1.66 32.52% | % | ||
| Q4 2021 Q2Q % growth | -0.67 73.20% | % | ||
| Q3 2021 Q2Q % growth | -1.43 -3.62% | -1.59 | 0.16 | 10.13% |
| Q2 2021 Q2Q % growth | -1.87 10.95% | -2.13 | 0.26 | 12.28% |
| Q1 2021 Q2Q % growth | -2.46 19.61% | -2.59 | 0.13 | 5.05% |
| Q4 2020 Q2Q % growth | -2.50 -177.78% | -1.51 | -0.99 | -65.61% |
| Q3 2020 Q2Q % growth | -1.38 50.00% | -1.82 | 0.44 | 23.99% |
| Q2 2020 Q2Q % growth | -2.10 36.36% | -2.94 | 0.84 | 28.46% |
| Q1 2020 Q2Q % growth | -3.06 8.93% | -2.54 | -0.52 | -20.63% |
| Q4 2019 Q2Q % growth | -0.90 | -2.48 | 1.58 | 63.71% |
| Q3 2019 Q2Q % growth | -2.76 | -3.13 | 0.37 | 11.87% |
| Q2 2019 Q2Q % growth | -3.30 | -6.47 | 3.17 | 49.00% |
| Q1 2019 Q2Q % growth | -3.36 | -5.74 | 2.38 | 41.44% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | 37.985M 20.59% | % | ||
| Q3 2023 Q2Q % growth | 27.72M -17.25% | % | ||
| Q2 2023 Q2Q % growth | 29.7M -4.50% | % | ||
| Q1 2023 Q2Q % growth | 22.3M -0.89% | % | ||
| Q4 2022 Q2Q % growth | 31.5M -14.86% | % | ||
| Q3 2022 Q2Q % growth | 33.5M 6.35% | % | ||
| Q2 2022 Q2Q % growth | 31.1M -2.20% | % | ||
| Q1 2022 Q2Q % growth | 22.5M -22.15% | % | ||
| Q4 2021 Q2Q % growth | 37M -3.14% | % | ||
| Q3 2021 Q2Q % growth | 31.5M -40.68% | 31.183M | 317K | 1.02% |
| Q2 2021 Q2Q % growth | 31.8M -5.36% | 30.536M | 1.264M | 4.14% |
| Q1 2021 Q2Q % growth | 28.9M 2.85% | 22.592M | 6.308M | 27.92% |
| Q4 2020 Q2Q % growth | 38.2M -24.36% | 34.68M | 3.52M | 10.15% |
| Q3 2020 Q2Q % growth | 53.1M 11.32% | 30.178M | 22.922M | 75.96% |
| Q2 2020 Q2Q % growth | 33.6M -32.93% | 27.953M | 5.647M | 20.20% |
| Q1 2020 Q2Q % growth | 28.1M -36.28% | 41.829M | -13.729M | -32.82% |
| Q4 2019 Q2Q % growth | 50.5M | 45.475M | 5.025M | 11.05% |
| Q3 2019 Q2Q % growth | 47.7M | 45.62M | 2.08M | 4.56% |
| Q2 2019 Q2Q % growth | 50.1M | 29.392M | 20.708M | 70.45% |
| Q1 2019 Q2Q % growth | 44.1M | 33.705M | 10.395M | 30.84% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |